APA (7th ed.) Citation

Blomberg, O. S., Kos, K., Spagnuolo, L., Isaeva, O. I., Garner, H., Wellenstein, M. D., . . . de Visser, K. E. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology, 12(1), 2201147. https://doi.org/10.1080/2162402X.2023.2201147

Chicago Style (17th ed.) Citation

Blomberg, Olga S., et al. "Neoadjuvant Immune Checkpoint Blockade Triggers Persistent and Systemic T Reg Activation Which Blunts Therapeutic Efficacy Against Metastatic Spread of Breast Tumors." Oncoimmunology 12, no. 1 (2023): 2201147. https://doi.org/10.1080/2162402X.2023.2201147.

MLA (9th ed.) Citation

Blomberg, Olga S., et al. "Neoadjuvant Immune Checkpoint Blockade Triggers Persistent and Systemic T Reg Activation Which Blunts Therapeutic Efficacy Against Metastatic Spread of Breast Tumors." Oncoimmunology, vol. 12, no. 1, 2023, p. 2201147, https://doi.org/10.1080/2162402X.2023.2201147.